193 related articles for article (PubMed ID: 6420434)
1. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
Braund W; Roeger DC; Judd SJ
J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
[TBL] [Abstract][Full Text] [Related]
2. Regulation of pulsatile secretion of progesterone during the human luteal phase.
Steele PA; Braund W; Judd SJ
Clin Reprod Fertil; 1986 Apr; 4(2):117-24. PubMed ID: 3742433
[TBL] [Abstract][Full Text] [Related]
3. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
5. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
6. Estrogenic modulation of the gonadotropin-releasing hormone-stimulated secretory activity of the gonadotrope and lactotrope in prepubertal females with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1991 Dec; 73(6):1202-9. PubMed ID: 1955502
[TBL] [Abstract][Full Text] [Related]
7. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
Cetel NS; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
[TBL] [Abstract][Full Text] [Related]
8. Effect of naloxone on luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in the different phases of the estrous cycle.
Piva F; Maggi R; Limonta P; Motta M; Martini L
Endocrinology; 1985 Aug; 117(2):766-72. PubMed ID: 3926461
[TBL] [Abstract][Full Text] [Related]
9. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
10. Sustained effects of opioid antagonism during the normal human luteal phase.
Gindoff PR; Jewelewicz R; Hembree W; Wardlaw S; Ferin M
J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-releasing action of a low dose of exogenous gonadotropin-releasing hormone throughout the human menstrual cycle.
Mais V; Melis GB; Paoletti AM; Strigini F; Antinori D; Fioretti P
Neuroendocrinology; 1986; 44(3):326-30. PubMed ID: 3100975
[TBL] [Abstract][Full Text] [Related]
12. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
[TBL] [Abstract][Full Text] [Related]
13. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of the luteal phase and its transition into the follicular phase.
Vermesh M; Kletzky OA
J Clin Endocrinol Metab; 1987 Oct; 65(4):653-8. PubMed ID: 3116029
[TBL] [Abstract][Full Text] [Related]
15. Effect of naloxone on GnRH-induced LH and FSH release in buffalo, Bubalus bubalis.
Palta P; Chandrasekhar T; Prakash BS; Madan ML
Indian J Exp Biol; 2000 Apr; 38(4):390-2. PubMed ID: 11218818
[TBL] [Abstract][Full Text] [Related]
16. Secretory patterns and rates of gonadotropin-releasing hormone, follicle-stimulating hormone, and luteinizing hormone revealed by intensive sampling of pituitary venous blood in the luteal phase mare.
Irvine CH; Alexander SL
Endocrinology; 1993 Jan; 132(1):212-8. PubMed ID: 8419124
[TBL] [Abstract][Full Text] [Related]
17. Hormone ontogeny in the ovine fetus. XXVII. Pulsatile and copulsatile secretion of luteinizing hormone, follicle-stimulating hormone, growth hormone, and prolactin in late gestation: a new method for the analysis of copulsatility.
Albers N; Bettendorf M; Herrmann H; Kaplan SL; Grumbach MM
Endocrinology; 1993 Feb; 132(2):701-9. PubMed ID: 8425489
[TBL] [Abstract][Full Text] [Related]
18. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
19. Effect of exogenous and endogenous gonadotropin-releasing hormone on prolactin secretion in perimenopausal women.
Cano A; Parrilla JJ; Abad L
Gynecol Obstet Invest; 1988; 26(4):308-12. PubMed ID: 3147927
[TBL] [Abstract][Full Text] [Related]
20. Estrogen dependence of the periovulatory plasma prolactin response to gonadotropin-releasing hormone in normal women.
Barbarino A; De Marinis L; Mancini A; D'Amico C; Minnielli S
Metabolism; 1983 Nov; 32(11):1059-62. PubMed ID: 6413811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
